Boston Scientific's (BSX) new acquisitions like Preventice, Farapulse and Lumenis Surgical, which closed in March, August and September of 2021, respectively, are contributing to its inorganic growth.
source http://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=0D24932FAC054F66A9C776B058C0D038&url=https%3a%2f%2fwww.entrepreneur.com%2farticle%2f403166&c=11868653826998193536&mkt=en-us
No comments:
Post a Comment